eCite Digital Repository

The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran

Citation

Rezapour, A and Palmer, AJ and Alipour, V and Hajahmadi, M and Jafari, A, The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran, Cost Effectiveness and Resource Allocation, 19, (1) pp. 1-9. ISSN 1478-7547 (2021) [Refereed Article]


Preview
PDF
Pending copyright assessment - Request a copy
3Mb
  

DOI: doi:10.1186/s12962-021-00334-z

Abstract

Background B-type natriuretic peptide (BNP) is commonly used as a diagnostic method for patients with heart failure. This study was designed to evaluate the cost-effectiveness of BNP compared to standard clinical assessment in outpatients with heart failure with reduced ejection fraction (HFrEF) in Tehran, Iran. Methods This study was a cost-effectiveness analysis carried on 400 HFrEF outpatients > 45 years who were admitted to Rasoul Akram General Hospital of Tehran, Iran. A Markov model with a lifetime horizon was developed to evaluate economic and clinical outcomes for BNP and standard clinical assessment. Quality-adjusted life-years (QALYs), direct, and indirect costs collected from the patients. Results The results of this study indicated that mean QALYs and cost were estimated to be 2.18 QALYs and $1835 for BNP and 2.07 and $2376 for standard clinical assessment, respectively. In terms of reducing costs and increasing QALYs, BNP was dominant compared to standard clinical assessment. Also, BNP had an 85% probability of being cost-effective versus standard clinical assessment if the willingness to pay threshold is higher than $20,800/QALY gained. Conclusion Based on the results of the present study, measuring BNP levels represents good value for money, decreasing costs and increasing QALYs compared to standard clinical assessment. It is suggested that the costs of the BNP test be covered by insurance in Iran. The result of the current study has important implications for policymakers in developing clinical guidelines for the diagnosis of heart failure.

Item Details

Item Type:Refereed Article
Keywords:Cost-efectiveness, Heart failure, B-type natriuretic peptide, Markov model, Risk factors, Management, Burden, Population, Diseases, Therapy.
Research Division:Economics
Research Group:Applied economics
Research Field:Health economics
Objective Division:Health
Objective Group:Evaluation of health and support services
Objective Field:Evaluation of health outcomes
UTAS Author:Palmer, AJ (Professor Andrew Palmer)
ID Code:152622
Year Published:2021
Deposited By:Medicine
Deposited On:2022-08-22
Last Modified:2022-08-22
Downloads:0

Repository Staff Only: item control page